Muscle Mass & Definition Cutting Cycle

Muscle Mass & Definition Cutting Cycle

  • $287.00



**3 x Ultima-Prop** - Ultima Pharmaceuticals [10 ml x 100 mg/ml] **1 x Ultima-Tren E 200** - Ultima Pharmaceuticals [10 ml x 200 mg/ml] **1 x Ultima-Stan 50** - Ultima Pharmaceuticals [50 pills x 50 mg] **1 x Ultima-Anastro** - Ultima Pharmaceuticals [50 pills x 1 mg] **1 x Ultima-Clomid** - Ultima Pharmaceuticals [50 pills x 50 mg] **2 x Ultima-Clen-Salbuto** - Ultima Pharmaceuticals [50 pills x 2 mg]
MANUFACTURER Ultima Pharmaceuticals - Cycles
WAREHOUSE International Warehouse 3
SUBSTANCE Anastrozole, Clomiphene Citrate, Stanozolol, Testosterone Propionate, Trenbolone Enanthate, Salbutamol

Brand: Ultima Pharmaceuticals

Transform Your Physique with the 6-Week Muscle Mass & Definition Cutting Cycle

Unleash your potential with this powerful cutting cycle designed to sculpt dry, aggressive muscle mass while enhancing definition. The unique blend of potent compounds delivers unparalleled intensity and quality, setting it apart from traditional bulking stacks. Experience a surge in energy, strength, and endurance from Testosterone, while Trenbolone and Winstrol provide robust power and substantial gains in solid, lean muscle with minimal water retention. Caution: Trenbolone may elevate aggression levels, so it's essential for athletes to assess their emotional responses.

This advanced cycle is not suitable for beginners or first-time users due to Trenbolone's potency. Committing to Post Cycle Therapy (PCT) is crucial for maintaining your hard-earned results post-cycle. Users can anticipate an impressive gain of about 12 kg of dry, lean muscle mass.

- **Ultima-Prop:** 300-500 mg per week - **Ultima-Tren E 200:** 200-300 mg per week - **Ultima-Stan 50:** 50 mg per day - **PCT:** Ultima-Clomid and Ultima-Clen-Salbuto for 3-4 weeks

Dosage Guidelines:

Please remember that we are not medical professionals, and our advice is based on personal experiences rather than expert recommendations.

OSGear disclaims any responsibility for complications arising during the cycle, misuse of products, or the outcomes achieved.